Table 1.
Study design for ProSCIUTTU
| LGG -BB12 (B) Active (186) | LGG -BB12 (b) Placebo (186) | |
|---|---|---|
| GR1-RC14 (A) Active (186) | AB or Intervention A (93) | Ab or Intervention B (93) |
| GR1-RC14 (a) Placebo (186) | aB or Intervention C (93) | ab or Intervention D (93) |
Study design for ProSCIUTTU
| LGG -BB12 (B) Active (186) | LGG -BB12 (b) Placebo (186) | |
|---|---|---|
| GR1-RC14 (A) Active (186) | AB or Intervention A (93) | Ab or Intervention B (93) |
| GR1-RC14 (a) Placebo (186) | aB or Intervention C (93) | ab or Intervention D (93) |